Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2026-01-07 @ 12:23 AM
Study NCT ID:
NCT03280160
Status:
UNKNOWN
Last Update Posted:
2022-09-16
First Post:
2017-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Protocol GELLC-7: Ibrutinib Followed by Ibrutinib Consolidation in Combination With Ofatumumab
Sponsor:
PETHEMA Foundation
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GELLC-7
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None